E-LIB Suche - Ergebnisse für: Schneitler, Sophie

1

SARS-CoV-2-specific cellular and humoral immunity after biv..:

Urschel, Rebecca ; Bronder, Saskia ; Klemis, Verena...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Hemophagocytic lymphohistiocytosis—how common and how sever..:

Orth, Hans Martin ; Wiemer, Dorothea ; Schneitler, Sophie...
Infection. 52 (2023) 2 - p. 471-482 , 2023

Link: https://doi.org/10.1007/..

3

Occurrence, resistance patterns, and management of carbapen..:

Berger, Fabian K. ; Schmartz, Georges P. ; Fritz, Tobias...
International Journal of Infectious Diseases. 132 (2023) - p. 89-92 , 2023

Link: https://doi.org/10.1016/..

4

Recipient-Reported Reactogenicity of Different SARS-CoV-2 V..:

Rau, Katharina ; von Heeringen, Edgar ; Bühler, Nina...
Vaccines. 11 (2023) 7 - p. 1147 , 2023

Link: https://doi.org/10.3390/..

5

Development of prevalence and incidence of non-tuberculous ..:

Corbett, Caroline ; Finger, Philipp ; Heiß-Neumann, Marion...
Emerging Microbes & Infections. 12 (2023) 2 - p. , 2023

Link: https://doi.org/10.1080/..

6

A multi-pronged approach to improve blood culture diagnosti..:

Neser, Elisabeth ; Jung, Philipp ; Halfmann, Alexander...
Infection. 52 (2023) 1 - p. 183-195 , 2023

Link: https://doi.org/10.1007/..

7

The state of infectious disease training in Germany before ..:

Bischoff, Jenny ; Schneitler, Viktoria ; Duettmann, Wiebke..
Infection. 51 (2023) 3 - p. 589-598 , 2023

Link: https://doi.org/10.1007/..

8

Differences in SARS-CoV-2 specific humoral and cellular imm..:

Ziegler, Laura ; Klemis, Verena ; Schmidt, Tina...
eBioMedicine. 95 (2023) - p. 104743 , 2023

Link: https://doi.org/10.1016/..

9

Is ipsilateral administration of COVID-19 vaccine boosters ..:

Ziegler, Laura ; Klemis, Verena ; Schmidt, Tina...
eBioMedicine. 98 (2023) - p. 104853 , 2023

Link: https://doi.org/10.1016/..

10

Differences in SARS-CoV-2 specific humoral and cellular imm..:

Ziegler, Laura ; Klemis, Verena ; Schmidt, Tina...
https://ars.els-cdn.com/content/image/1-s2.0-S2352396423003080-mmc1.docx. , 2023

Link: http://nbn-resolving.org..

11

Development of prevalence and incidence of non-tuberculous ..:

Caroline Corbett ; Philipp Finger ; Marion Heiß-Neumann...
doi:10.6084/m9.figshare.24444730.v2. , 2023

Link: https://doi.org/10.6084/..

12

Occurrence, resistance patterns, and management of carbapen..:

Berger, Fabian K ; Schmartz, Georges P ; Fritz, Tobias...
https://ars.els-cdn.com/content/image/1-s2.0-S1201971223005234-mmc1.docx. , 2023

Link: http://nbn-resolving.org..

13

Is ipsilateral administration of COVID-19 vaccine boosters ..:

Ziegler, Laura ; Klemis, Verena ; Schmidt, Tina...
http://nbn-resolving.org/urn:nbn:de:bsz:291--ds-414798. , 2023

Link: http://nbn-resolving.org..

14

Is ipsilateral administration of COVID-19 vaccine boosters ..:

Laura Ziegler ; Verena Klemis ; Tina Schmidt...
http://www.sciencedirect.com/science/article/pii/S235239642300419X. , 2023

Link: https://doi.org/10.1016/..

15

Development of prevalence and incidence of non-tuberculous ..:

Corbett, Caroline ; Finger, Philipp ; Heiß-Neumann, Marion...
https://freidok.uni-freiburg.de/data/241579. , 2023

Link: https://freidok.uni-frei..